19 Geographic Atrophy Clinical Trials in Columbus, OH (2026)

Q: How do I join a clinical trial in Columbus?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you.

Recruiting Geographic Atrophy Studies in Columbus

NCT05374824Recruiting

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

Lennox-Gastaut syndrome is a serious and rare form of epilepsy that begins in infancy and early childhood. Seizures and their consequences need medical attention, emergency encounters, and hospitaliza...

Columbus, OH4,680 participantsAnn & Robert H Lurie Children's Hospital of Chicago

View Study Details

NCT03199651Recruiting

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may...

Columbus, OHNA3,584 participantsOhio State University Comprehensive Cancer Center

View Study Details

NCT06260683Recruiting

A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior

This clinical trial compares the use of tobacco flavored electronic cigarettes (ECs) vs. non-tobacco flavored ECs vs. nicotine replacement therapy (patches and lozenges) on smoking behavior in current...

Columbus, OHNA1,500 participantsOhio State University Comprehensive Cancer Center

View Study Details

NCT06763536Recruiting

Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia

This clinical trial compares the use of oral nicotine pouches to nicotine replacement therapy, consisting of nicotine patches and lozenges, to reduce cigarette use in smokers living in rural Appalachi...

Columbus, OHNA1,000 participantsOhio State University Comprehensive Cancer Center

View Study Details

NCT05880199Recruiting

BSGM to Evaluate Patients With GI Symptoms

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with G...

Columbus, OH685 participantsChildren's Hospital of Philadelphia

View Study Details

NCT06796790Recruiting

Literacy Instruction Through Media for Everyone

The goal of this study is to determine whether an intervention to support caregivers in engaging with their children while using educational media together can improve children's early literacy skills...

Columbus, OHNA450 participantsOhio State University

View Study Details

NCT07717554Recruiting

Effect of Virtual Yoga in Diabetic Gastroparesis Patients

The purpose of this study is to investigate the potential benefits of an online yoga module for patients with gastroparesis. Specifically, the study aims to: 1. Evaluate the Impact of Yoga Practices:...

Columbus, OHNA240 participantsOhio State University

View Study Details

NCT07419334Recruiting

Study of ALK-001 on the Progression of Stargardt Disease

This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (ST...

Columbus, OHPHASE3230 participantsAlkeus Pharmaceuticals, Inc.

View Study Details

NCT05981300Recruiting

GpCRC Pediatric Gastroparesis Registry 2

The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symp...

Columbus, OH216 participantsJohns Hopkins Bloomberg School of Public Health

View Study Details

NCT06022029Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or recommended dose for expan...

Columbus, OHPHASE1168 participantsOncoNano Medicine, Inc.

View Study Details

NCT07692789Recruiting

Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems

The purpose of this study is to evaluate the impact of pre-procedure patient reminder systems on patient satisfaction, preparedness, and anxiety among patients undergoing urodynamics studies. The rate...

Columbus, OHNA162 participantsOhio State University

View Study Details

NCT06930625Recruiting

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

The primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind per...

Columbus, OHPHASE3119 participantsDebiopharm International SA

View Study Details

NCT07641179Recruiting

A Study to Evaluate MAR002 for Acromegaly

Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in participants with acromegaly...

Columbus, OHPHASE272 participantsMarea Therapeutics

View Study Details

NCT06989359Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

This Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated kidney diseases....

Columbus, OHPHASE245 participantsADARx Pharmaceuticals, Inc.

View Study Details

NCT07111234Recruiting

Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences

This clinical trial studies how the flavors and synthetic coolant properties in oral nicotine pouches (ONPs) compare to one another and how these characteristics are perceived by users. ONPs are place...

Columbus, OHNA30 participantsOhio State University Comprehensive Cancer Center

View Study Details

NCT07455513Recruiting

A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer

This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single m...

Columbus, OHNA30 participantsOhio State University Comprehensive Cancer Center

View Study Details

NCT06797518Recruiting

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

A study to investigate the impact of iptacopan treatment on the underlying immunopathology in patients with IgAN by assessing changes in key clinical and molecular markers from baseline to 9 months. T...

Columbus, OHPHASE220 participantsNovartis Pharmaceuticals

View Study Details

NCT03266640Recruiting

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovi...

Columbus, OHPHASE220 participantsNew York Medical College

View Study Details

NCT06563323Recruiting

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

A single-arm open-label study assessing short-term (week 6, 16) and long-term (week 32) efficacy of guselkumab in adult participants with pyoderma gangrenosum (PG)...

Columbus, OHPHASE217 participantsOregon Health and Science University

View Study Details

About Geographic Atrophy Clinical Trials in Columbus

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 19 geographic atrophy clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 13,268 participants. Research is being sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, Ohio State University Comprehensive Cancer Center, Children's Hospital of Philadelphia and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Columbus — FAQ

Are there geographic atrophy clinical trials in Columbus?

Yes, there are 19 geographic atrophy clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbus?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.

Are clinical trials in Columbus free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 19 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated September 3, 2026 from ClinicalTrials.gov